Institut Esthederm
$34.92 · Serum
Your profile match
Community
Not enough reports yet (0/3).
Ideal for
Caution
May aggravate: Atopic Dermatitis / Eczema (Salicylic Acid and Propylene Glycol); Seborrheic Dermatitis (Cetyl Alcohol); Rosacea (Propylene Glycol)
Set up a profile to see which of these apply to you.
Apply to effected area. Full
Key actives
Aqua/Water/Eau*, Propanediol, Propylheptyl Caprylate, Methylpropanediol, Salicylic Acid, Potassium Cetyl Phosphate, Silica, Zinc Gluconate, Polyglyceryl-6 Distearate, Propolis Extract, Xanthan Gum, Sodium Hydroxide, Polyacrylamide, Jojoba Esters, C13-14 Isoparaffin, Cetyl Alcohol, Polyglyceryl-3 Beeswax, Aminoethanesulfinic Acid, Pentaerythrityl Tetra-Di-T-Butyl Hydroxyhydrocinnamate, Propylene Glycol, Laureth-7, Carnosine, Tocopherol, Disodium Adenosine Triphosphate, Laminaria Digitata Extract, Benzyl Alcohol, Anise Alcohol, Benzyl Benzoate, Benzyl Cinnamate, Benzyl Salicylate, Cinnamyl Alcohol, Eugenol, Isoeugenol. [Z070] *Cellular Water (Aqua/Disodium Adenosine Triphosphate/Carnosine/Mineral Salts). For the latest information, it is recommended to review the ingredient list printed on the packaging of the product prior to usage or consumption.
30 studies on 9of this product’s ingredients. These study the ingredient, not this product.
Dermatology and Therapy, 2015 · n=120 · systematic-review
Systematic review of keratolytics and emollients in psoriasis therapy: salicylic acid is a key keratolytic that removes psoriatic scale and improves penetration of co-applied topical agents; supports salicylic acid as an evidence-based adjunctive (descaling) treatment rather than a standalone therapy.
Clinical, Cosmetic and Investigational Dermatology, 2015 · systematic-review
Comprehensive review: salicylic acid (2%) is the only lipophilic BHA, enabling comedolytic and anti-inflammatory activity within the pilosebaceous unit; effective for acne vulgaris, melasma, photodamage, and keratosis pilaris; 20-30% SA peels show efficacy comparable to glycolic acid peels with lower erythema risk in Fitzpatrick IV-VI
Journal of the European Academy of Dermatology and Venereology, 2011 · n=50 · rct
Single-blind RCT (n=46, 12 weeks) in mild-to-moderate acne comparing salicylic acid 3% plus clindamycin with tretinoin 0.05% plus clindamycin: both significantly reduced inflammatory and non-inflammatory lesion counts; tretinoin acted faster (significant by week 2) but groups were comparable at 12 weeks, and both were well tolerated.
Used this product? Sign in to share your outcome and see what people with your skin reported.
Sign in to add your experienceNo reports yet. Be the first to share your experience.
Community outcomes are self-reported member experiences, shown separately from the evidence score — never blended into it. Educational, not medical advice.